Taeg Kim

Taeg Kim is a highly experienced Director in Immunology with a strong background in in vitro and in vivo immunopharmacology, target identification/validation, and drug discovery and development for Immuno-Oncology and Inflammatory Disease therapy. Throughout their career, they have led cross-functional teams in various companies such as HotSpot Therapeutics, Inc., Compass Therapeutics Inc., Bristol-Myers Squibb, and Jnana Therapeutics, showcasing expertise in innate and adaptive immune responses. With a Ph.D. in Immunology from the University of Iowa, they have a track record of success in pre-clinical mechanistic models of disease and have made significant contributions to the field through their publications and mentorship of students.